Trial Profile
A controlled phase IIb study of OPRX-106 for the treatment of ulcerative colitis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 19 Nov 2018
Price :
$35
*
At a glance
- Drugs PRX 106 (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 19 Nov 2018 New trial record